AU2001295558A1 - Variants of phleum pratense allergenic proteins - Google Patents

Variants of phleum pratense allergenic proteins

Info

Publication number
AU2001295558A1
AU2001295558A1 AU2001295558A AU9555801A AU2001295558A1 AU 2001295558 A1 AU2001295558 A1 AU 2001295558A1 AU 2001295558 A AU2001295558 A AU 2001295558A AU 9555801 A AU9555801 A AU 9555801A AU 2001295558 A1 AU2001295558 A1 AU 2001295558A1
Authority
AU
Australia
Prior art keywords
variants
phleum pratense
allergenic proteins
pratense
phleum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295558A
Inventor
Paolo Falagiani
Giovanni Mistrello
Daniela Roncarolo
Monica Sturaro
Angelo Viotti
Stefania Zanotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consiglio Nazionale delle Richerche CNR
Original Assignee
Consiglio Nazionale delle Richerche CNR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11445783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001295558(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Consiglio Nazionale delle Richerche CNR filed Critical Consiglio Nazionale delle Richerche CNR
Publication of AU2001295558A1 publication Critical patent/AU2001295558A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Hypoallergenic variants of the major allergen Ph1 p 1 of Phleum pratense plants and their use in the therapy of the allergic diseases is disclosed.
AU2001295558A 2000-09-12 2001-09-11 Variants of phleum pratense allergenic proteins Abandoned AU2001295558A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI200A001987 2000-09-12
IT2000MI001987A IT1318692B1 (en) 2000-09-12 2000-09-12 VARIATIONS OF ALLERGENIC PROTEINS OF PHLEUM PRATENSE.
PCT/EP2001/010485 WO2002022679A2 (en) 2000-09-12 2001-09-11 Variants of phleum pratense allergenic proteins

Publications (1)

Publication Number Publication Date
AU2001295558A1 true AU2001295558A1 (en) 2002-03-26

Family

ID=11445783

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295558A Abandoned AU2001295558A1 (en) 2000-09-12 2001-09-11 Variants of phleum pratense allergenic proteins

Country Status (8)

Country Link
US (1) US7029686B2 (en)
EP (1) EP1317484B2 (en)
AT (1) ATE293128T1 (en)
AU (1) AU2001295558A1 (en)
DE (1) DE60110096T3 (en)
ES (1) ES2238487T5 (en)
IT (1) IT1318692B1 (en)
WO (1) WO2002022679A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1062341T3 (en) * 1998-03-16 2008-11-03 Alk Abello As Mutant recombinant allergens
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
AU2003251674B2 (en) 2002-08-19 2009-09-03 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
ES2397778T3 (en) 2003-06-04 2013-03-11 Merck Patent Gmbh Derivatives of POA P 5 with reduced allergenicity and reactivity against T cells maintained
ITMI20112301A1 (en) 2011-12-19 2013-06-20 Lofarma Spa HYPOALLERGENIC VARIATIONS OF THE ALLERGEN HIGHER PHL P 5 OF PHLEUM PRATENSE
GB201200259D0 (en) * 2012-01-09 2012-02-22 Ohlin Per M Novel therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713001A1 (en) * 1997-03-27 1998-10-01 Merck Patent Gmbh Gramina pollen allergen mutants for specific immunotherapy, their production and use
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
DK1062341T3 (en) * 1998-03-16 2008-11-03 Alk Abello As Mutant recombinant allergens

Also Published As

Publication number Publication date
US20020064530A1 (en) 2002-05-30
US7029686B2 (en) 2006-04-18
EP1317484B2 (en) 2011-01-05
ES2238487T5 (en) 2011-04-08
WO2002022679A2 (en) 2002-03-21
ITMI20001987A0 (en) 2000-09-12
IT1318692B1 (en) 2003-08-27
WO2002022679A3 (en) 2002-05-30
ES2238487T3 (en) 2005-09-01
DE60110096D1 (en) 2005-05-19
DE60110096T3 (en) 2011-07-21
DE60110096T2 (en) 2006-03-02
EP1317484A2 (en) 2003-06-11
ITMI20001987A1 (en) 2002-03-12
ATE293128T1 (en) 2005-04-15
EP1317484B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
EP2270046A3 (en) Methods and compositions for the treatment of hemolysis-associated diseases
IL115733A0 (en) Binding agents and their use for therapeutic treatment
AU2001286171A1 (en) Human cDNAs and proteins and uses thereof
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
IS6967A (en) New cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
AU2001295558A1 (en) Variants of phleum pratense allergenic proteins
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
EP1416795A4 (en) Compositions and methods for treatment of mitochondrial diseases
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
EP1645285A3 (en) Therapeutical use of anti-mag antibody for the treatment of ischemic stroke
FR2845991B1 (en) ALPHA-PHENYL ACETANILIDE DERIVATIVES AND THEIR USE IN HUMAN THERAPEUTICS
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AU2002212230A1 (en) Variants of the major allergen par j 2 of parietaria judaica
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
UA2163C2 (en) Biologically MEANS THAT HAS immunomodulating property, the way it is received, preparations based on it NORMALIZATION AND METHOD physiological state of the human body and animals in diseases generated MAINLY functional insufficiency of organs and tissues, using such preparation
AU2003219618A1 (en) System designed to generate programmed sequences of stimuli resulting in controlled and persistent physiological responses in the body
AU2002302618A1 (en) 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
AU2002365510A1 (en) Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
AUPM533894A0 (en) Prophylactic and therapeutic treatment of pathogenic infections in plants and animals
AU2003208289A1 (en) Deuterated spirocyclopentanimidazolinones and the use thereof in the treatment of cardiovascular diseases